ABOUT I-VASC
I-VASC Team collectively owns decades of experience in innovative minimally invasive devices, from product development to clinical application, market access and global commercialization

START

I-VASC was founded in 2015 with the goal of introducing its patented Empty Vein Ablation (EVA) technology for the minimally invasive treatment of varicose veins to the global market.

RESULTS

I-VASC successfully moved from a conceptual idea to an innovative and fully validated product, by obtaining in 2021 the CE Mark certification for its VELEX™ system, catheter and handle

NEXT STEPS

I-VASC Team is committed to make VELEX™ and E.V.A. procedure commercially available to for patients and doctors around the world, and to develop new applications for its technology platform

PATENTS

The Empty Vein Ablation (EVA) technology is protected by a IP portfolio of several patents granted in all relevant global geographies

ENDORSMENTS

The I-VASC technology has received the endorsement of several global Key Opinion Leaders in vascular therapies

PATENTS

Six patents granted and Seven pending

PROTOTYPES

Four different series of prototypes developed

ENDORSMENTS

Key Opinion Leader endorsement

TESTED

Positive in ex vivo and in vivo pre-clinical testing

OUR TEAM

Management Team

Mario Salerno
Mario Salerno
President & CMO - Founder & Inventor
Experienced vascular surgeon, Dep. Head at Maugeri IRCCS. Over 25-year experience and 18,000 sclerotherapy procedures performed.
Cristiano Fontana
Cristiano Fontana
Business Dev & Board Member
Senior Manager with 20 years experience in MedTech business dev, strategic advisory, fund raising value creation and commercialization
Stefano Firpo
Stefano Firpo
Board Member - Financial
Senior Manager with 25 years experience as Economist between business, banking and public policies
Elena Abbruzzese
Elena Abbruzzese
Project Manager
Biomedical Engineer graduated from Politecnico di Milano, been working for more than seven years as a Project Manager in the field of Medical Devices. Experiences vary from the development and industrialization of medical products to the management of the product once it is on the market.
Alessandro Stella
Alessandro Stella
RAQA Manager
Medical device expert with in depth knowledge EU MDR and IVDR, MDCG guidelines, clinical evaluation and investigation, regulatory strategy.

Business Advisors

Milena Baselli
Milena Baselli
Business Development
PhD in experimental physics, Executive Master in Finance at SDA Bocconi School of Management with major in corporate finance.
Claudio Giuliano
Claudio Giuliano
Advisor
Founder and Managing Partner Innogest (VC) and Groupack Holding (private Equity)

Scientific Advisors

Sergio Gianesini
Sergio Gianesini
Medical Board
Internationally recognized expert in venous and lymphatic disease, surgeon at the University of Ferrara (Italy), adjunct associate professor at the Uniformed Services University of Health Sciences (Bethesda, USA). He published more than 70 papers on venous-lymphatic topics, being invited as international speaker in more than 300 meetings. He has active roles in some of the most relevant international venous-lymphatic societies
Willy Chi
Willy Chi
Medical Board
Internationally recognized authority on venous and lymphatic disease, Professor of Medicine at the University of California, Davis, Vascular Center. He is widely published in the field of venous and lymphatic disease, and lectures globally. He is on the editorial board of Phlebology, Vascular Medicine, Veins and Lymphatic, and the Chinese Medical Journal
Sriram Narayanan
Sriram Narayanan
Medical Board
Experienced Chief Consultant with a demonstrated history of working in the hospital & health care industry. Skilled in Vascular, Clinical Research, Medical Education, Medical Devices, and Medicine. Expertise in medical device development, complex venous and aortic surgery